IRCT20200922048804N1
Completed
未知
Inflammation control in patients with COVID-19 using melatonin supplement compare to controls referred to Imam Khomani Hospital
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •mild to moderate patients with COVID\-19 who receive Hydroxy chloroquine
- •Confirmation of the disease is based on CT scan and clinical symptoms and physician diagnosis
- •Patients 25\-65 years
Exclusion Criteria
- •Patient with depression, COPD, sleep apnea and seizure
- •Patients with severe kidney problem (eGFR\<30 ml/min)
- •Patients with severe liver problem
- •Patients who receive fluvoxamine, benzodiazepine or zolpidem
- •patients who receive drugs that extends QT
- •Pregnant and breastfeeding mothers
- •Patients who have allergy to melatonin
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment with Omega-3 polyunsaturated fatty acids in COVID-19 patients.A single-blind, randomized, placebo-controlled feasibility study.SARS-COV-2 InfectionMedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-002293-28-SEKarolinska University Hospital40
Recruiting
Phase 2
Treatment of COVID-19-induced cytokine storm by hemoperfusioIRCT20200317046797N5Tabriz University of Medical Sciences10
Recruiting
Not Applicable
Immune response and therapy assessment to COVID-19 Vaccinations in people with Diabetes Mellitus – an observational pilot studyE10E11Type 1 diabetes mellitusType 2 diabetes mellitusDRKS00024879Division Exercise Physiology and Metabolism60
Not yet recruiting
Phase 2
se of Steroid inhalers in COVID.CTRI/2021/05/033817YOU BREATHE WE CARE
Recruiting
Not Applicable
COVID-19 in patients with chronic inflammatory diseases: a prospective cohort studycoronavirusCOVID-191000381610047438NL-OMON54401Reade8,000